186 related articles for article (PubMed ID: 36710400)
1. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States.
Kim N; Hwang CY; Kim T; Kim H; Cho KH
Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition.
Buonato JM; Lazzara MJ
Cancer Res; 2014 Jan; 74(1):309-19. PubMed ID: 24108744
[TBL] [Abstract][Full Text] [Related]
5. Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.
Zhao Y; Tian B; Sadygov RG; Zhang Y; Brasier AR
J Proteomics; 2016 Oct; 148():126-38. PubMed ID: 27461979
[TBL] [Abstract][Full Text] [Related]
6. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
9. Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.
Reka AK; Kuick R; Kurapati H; Standiford TJ; Omenn GS; Keshamouni VG
J Thorac Oncol; 2011 Nov; 6(11):1784-92. PubMed ID: 21964532
[TBL] [Abstract][Full Text] [Related]
10. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.
Hong SK; Park JR; Kwon OS; Kim KT; Bae GY; Cha HJ
Cancer Lett; 2016 Jul; 376(2):339-46. PubMed ID: 27085460
[TBL] [Abstract][Full Text] [Related]
11. SNAIL driven by a feed forward loop motif promotes TGF
Bhavani GS; Palanisamy A
Biomed Phys Eng Express; 2022 Jun; 8(4):. PubMed ID: 35700712
[TBL] [Abstract][Full Text] [Related]
12. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
13. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
14. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 activation is required for transforming growth factor β-induced epithelial-mesenchymal transition.
Kim S; Ham S; Yang K; Kim K
Mol Oncol; 2018 Oct; 12(10):1811-1826. PubMed ID: 30171795
[TBL] [Abstract][Full Text] [Related]
16. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
19. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution.
Karacosta LG; Anchang B; Ignatiadis N; Kimmey SC; Benson JA; Shrager JB; Tibshirani R; Bendall SC; Plevritis SK
Nat Commun; 2019 Dec; 10(1):5587. PubMed ID: 31811131
[TBL] [Abstract][Full Text] [Related]
20. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
